Cargando…

Multitarget Therapeutics for Neurodegenerative Diseases

Detalles Bibliográficos
Autores principales:	Gabr, Moustafa T., Yahiaoui, Samir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361872/ https://www.ncbi.nlm.nih.gov/pubmed/32695817 http://dx.doi.org/10.1155/2020/6532827

Ejemplares similares

Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations
por: Maramai, Samuele, et al.
Publicado: (2020)

Multitarget therapeutic strategies for Alzheimer’s disease
por: Ibrahim, Mostafa M., et al.
Publicado: (2019)

Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer’s and Other Neurodegenerative Diseases
por: Cornec, Anne-Sophie, et al.
Publicado: (2017)

Fine-Tuning the Biological Profile of Multitarget Mitochondriotropic Antioxidants for Neurodegenerative Diseases
por: Chavarria, Daniel, et al.
Publicado: (2021)

Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders
por: Quezada, Elías, et al.
Publicado: (2021)

Xanthine–Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases
por: Załuski, Michał, et al.
Publicado: (2023)

Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study
por: Iqbal, Danish, et al.
Publicado: (2022)

Special issue on neurodegenerative diseases and their therapeutic approaches
por: Kim, Jungsu, et al.
Publicado: (2015)

Synthesis and Biological Evaluation of Dantrolene‐Like Hydrazide and Hydrazone Analogues as Multitarget Agents for Neurodegenerative Diseases
por: Bolognino, Isabella, et al.
Publicado: (2021)

Rivastigmine–Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases
por: Vicente-Zurdo, David, et al.
Publicado: (2023)

Recent Advances and Future Perspectives in the Development of Therapeutic Approaches for Neurodegenerative Diseases
por: Bowerman, Melissa
Publicado: (2020)

The urgent need for pan-antiviral agents: from multitarget discovery to multiscale design
por: V Kleandrova, Valeria, et al.
Publicado: (2020)

Mitochondria in neurodegenerative diseases
por: Lin, Fang, et al.
Publicado: (2019)

Biomarkers in Neurodegenerative Diseases
por: Ghosh, Arnab
Publicado: (2022)

Advances in Neurodegenerative Diseases
por: Siokas, Vasileios, et al.
Publicado: (2022)

Advances in Neurodegenerative Diseases
por: Van Schependom, Jeroen, et al.
Publicado: (2023)

Lipids in Neurodegenerative Diseases
por: Chiurchiù, Valerio
Publicado: (2023)

GABA Signaling: Therapeutic Targets for Neurodegenerative and Neurodevelopmental Disorders
por: Cherubini, Enrico, et al.
Publicado: (2023)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

Selecting Multitarget Peptides for Alzheimer’s Disease
por: Kasus-Jacobi, Anne, et al.
Publicado: (2022)

Neuroplasticity in the Pathology of Neurodegenerative Diseases
por: Dorszewska, Jolanta, et al.
Publicado: (2020)

Neurodegenerative Diseases: Mechanisms and Therapies
por: Smith, Mark A., et al.
Publicado: (2006)

Protein Misfolding and Neurodegenerative Diseases
por: Cardinale, Alessio, et al.
Publicado: (2014)

Pain Assessment in Neurodegenerative Diseases
por: de Tommaso, Marina, et al.
Publicado: (2016)

Biochemical Biomarkers and Neurodegenerative Diseases
por: Ciaccio, Marcello
Publicado: (2021)

Oxidative Stress in Neurodegenerative Diseases
por: Domanskyi, Andrii, et al.
Publicado: (2022)

Protein Kinases and Neurodegenerative Diseases
por: Kawahata, Ichiro, et al.
Publicado: (2023)

From Single Target to Multitarget/Network Therapeutics in Alzheimer’s Therapy
por: Zheng, Hailin, et al.
Publicado: (2014)

Therapeutic Potential and Pharmaceutical Development of a Multitargeted Flavonoid Phloretin
por: Nakhate, Kartik T., et al.
Publicado: (2022)

Could exercise hormone irisin be a therapeutic agent against Parkinson’s and other neurodegenerative diseases?
por: Avgerinos, Konstantinos I., et al.
Publicado: (2023)

Overcoming gaps in the treatment of neurodegenerative disease
Publicado: (2020)

Traditional Medicine for Treatment of Neurodegenerative Diseases
por: Wu, Chun Fu, et al.
Publicado: (2014)

Oxidative Stress in Neurodegenerative Diseases and Ageing
por: Pereira, Marcos D., et al.
Publicado: (2012)

Imaging Neurodegenerative Diseases: Mechanisms and Interventions
por: Bai, Lijun, et al.
Publicado: (2014)

IDOL in metabolic, neurodegenerative and cardiovascular disease
por: van Loon, Nienke M., et al.
Publicado: (2018)

Marijuana's potential in neurodegenerative diseases: an editorial
por: Arachchige, Arosh S. Perera Molligoda
Publicado: (2023)

Prevention, Intervention and Care of Neurodegenerative Diseases
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Neurodegenerative Diseases: Molecular Mechanisms and Therapies
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
por: Marotta, Giambattista, et al.
Publicado: (2020)

Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches
por: Cabaud-Gibouin, Vincent, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_da2gbscpr4dg97eh0k289p75lc